top of page


VenoVision takes the power of ICU-grade biometrics to the whole new level of an AI-enabled Contactless Patient Monitoring Platform.

Today, undetected patient deterioration is leading to ever-rising costs and harming patients’ lives, their families, care teams and the overall quality of healthcare. We at VenoVision are developing the next generation of monitoring – a safe, reliable, cost-effective, and affordable algorithmic-driven system to alert medical staff before the patient’s condition spirals downward.

The current patent-pending technology is designed to improve outcomes in cardiopulmonary and cardio-renal patients, for which the company is conducting clinical trials to collect evidence-based results, to be followed by studies for regulatory approvals.

截圖 2020-07-19 下午4.56.40.png

Jonathan Maron

bottom of page